Skip to main content

Table 1 Differences in the clinical characteristics of class 1 (non-neovascularization) and class 2 (neovascularization) determined by CEUS

From: An assessment of the vulnerability of carotid plaques: a comparative study between intraplaque neovascularization and plaque echogenicity

 

Class 1 (n = 16)

Class 2 (n = 30)

P-value

Age (years), mean ± SD

64.38 ± 11.32

61.50 ± 6.26

0.186

Men, n (%)

16 (100%)

27 (90%)

0.542

Neurological symptoms*, n (%)

6 (37.5%)

18 (60%)

0.217

Hypertension, n (%)

9 (56.3%)

13 (43.3%)

0.538

Diabetes mellitus, n (%)

3 (18.8%)

9 (30.0%)

0.498

Hypercholesterolemia, n (%)

9 (56.3%)

18 (60.0%)

1.000

Current smoker, n (%)

8 (50.5%)

19 (63.3%)

0.531

  1. *Neurological symptoms include previous transient ischemic attacks (TIA), dysphasia, single limb paresis, and amaurosis fugax.